| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 03/03/2004 | EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same |
| 03/03/2004 | CN1478505A Capsule for delayed senility and its manufacturing method |
| 03/03/2004 | CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us |
| 03/02/2004 | US6699716 In vivo induction for enhanced function of isolated hepatocytes |
| 02/26/2004 | WO2004016272A1 Use of reboxetine for the treatment of hot flashes |
| 02/26/2004 | WO2003106505A9 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003045334A3 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 02/26/2004 | WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2002055067A3 Fumaric acid derivatives as nf-kappab inhibitors |
| 02/26/2004 | WO2002042336A3 Fgf-affinity chromatography |
| 02/26/2004 | WO2002022112A3 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 02/26/2004 | US20040039045 (2-azabicyclo(2.2.1)hept-7yl)methylcarbamate derivatives are useful for treating schizophrenia, Alzheimer's disease, neurodegenerative disorders, Parkinson's disease, Tourette's syndrome, age related memory loss and withdrawal symptoms |
| 02/26/2004 | US20040039017 Heterocyclic amines such as 2-(3-(4-Chloro-3-trifluoromethyl-benzylamino)prop-1-ylamino)-1H-quinolin-4 -one, used as G-protein coupled receptor inhibitors, for prophylaxis of cardiovascular disorders, schizophrenia or diabetes |
| 02/26/2004 | US20040038878 Injectable protein formulations |
| 02/26/2004 | CA2495452A1 Use of reboxetine for the treatment of hot flashes |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1390028A2 Use of lipoic acid for suppressing undesired haematological effects of chemotherapy and/or radiotherapy |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | CN1478081A Substituted 2-znilino-benzimidazoles and use thereof as NHE-inhibitors |
| 02/25/2004 | CN1476830A Tea-polyphenol soft capsule and its preparation process |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696428 Use of dopamine receptor antagonists in palliative tumor therapy |
| 02/24/2004 | US6696088 Useful for decreasing the potential for abuse of the opioid agonist contained therein; for use in therapy of pain |
| 02/24/2004 | CA2293461C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 02/21/2004 | CA2437664A1 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 02/19/2004 | WO2004014927A1 Mitochondrially targeted antioxidants |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014413A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 02/19/2004 | WO2003075850A9 Methods for alzheimer's disease treatment and cognitive enhancement |
| 02/19/2004 | WO2003070188A3 Method of treating trx mediated diseases |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2001020981A3 Anti-infective compositions for treating disordered tissue such as cold sores |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034100 Treating neuronal injury and for life-extension |
| 02/19/2004 | US20040034093 Methods for enhancing motor performance and/or endurance |
| 02/19/2004 | US20040033946 Cell damage inhibitor |
| 02/19/2004 | US20040033936 Reduced or "leuco" forms produced and/or stabilised by mixing the unreduced compounds or the reduced compounds, respectively, with acid and a sulphydryl compound, especially a sulphur-containing amino acid, or peptide or derivative |
| 02/19/2004 | CA2495518A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | CA2494156A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 02/19/2004 | CA2494026A1 Phosphodiesterase 4 inhibitors |
| 02/18/2004 | EP1389181A2 Antioxidant nitroxides and nitrones as therapeutic agents |
| 02/18/2004 | EP1389112A2 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 02/18/2004 | EP0980365B1 method for the preparation of alpha-tocopherol-4-aminobenzoic acid ester compounds |
| 02/18/2004 | CN1475492A Hongjingtian glycoside derivative and its preparation method and use |
| 02/18/2004 | CN1138552C Polyphenol extract of tea, use thereof and formulations containing same |
| 02/18/2004 | CN1138550C Process of producing extracts of shark |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693086 Eliciting nonantigen and strong antigen specific immune response; cancer, allergic inflammation and/or infectious disease prevention |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | CA2079161C N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines |
| 02/12/2004 | WO2004013108A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | WO2004012753A1 Pharmaceutical composition containing black cumin oil, flax oil and borago oil |
| 02/12/2004 | WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof |
| 02/12/2004 | WO2004012522A1 Compositions comprising lactoferrin |
| 02/12/2004 | WO2003057141A3 Methods for improving the aesthetic appearance of skin |
| 02/12/2004 | WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029912 Bicyclic derivatives |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040028758 Antioxidant composition and method of preparation thereof |
| 02/12/2004 | US20040028696 Kefir as a potent anti-oxidant composition |
| 02/12/2004 | US20040028643 Compositions for retarding skin aging |
| 02/12/2004 | CA2494408A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | CA2397684A1 Mitochondrially targeted antioxidants |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388343A1 Antioxidant composition and method of preparation thereof |
| 02/11/2004 | EP1387686A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection |
| 02/11/2004 | EP1328282A4 Efficient method for producing compositions enriched in anthocyanins |
| 02/11/2004 | EP1300394B1 Method for the production of a water-dispersible formulation containing carotenoids |
| 02/11/2004 | CN1474698A Formulation containing phosphate derivatives of electron transfer agents |
| 02/11/2004 | CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689741 Biocompatible polymers, process for their preparation and compositions containing them |
| 02/10/2004 | US6689349 Aging, ultraviolet radiation |
| 02/05/2004 | WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | WO2004011028A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | WO2004010990A1 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 02/05/2004 | WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases |
| 02/05/2004 | US20040024060 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/05/2004 | US20040023941 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and |
| 02/05/2004 | US20040023893 Coumarin derivatives for treatment of vascular disorders, skin disorders or allergies |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023332 Genes of il-12p40 subunit mutated for improving the activity of il-12 and thereof for dna vaccine adjuvant |
| 02/05/2004 | US20040023291 Comprises insect polypeptide for use in hemolysis and immunosuppression; immunotherapy |
| 02/05/2004 | US20040022879 Platelet Activating Factor Inhibitor and an antioxidant which interferes with the arachidonic acid cascade and also has antioxidant activity; especially useful for treating asthma in children. |